Venus Concept (VERO) 10-Q 14 Aug 23 2023 Q2 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	6 Months Ended
	Jun. 30, 2023	Aug. 09, 2023
Document Information [Line Items]
Entity Central Index Key	0001409269
Entity Registrant Name	Venus Concept Inc.
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2023
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2023
Document Transition Report	false
Entity File Number	001-38238
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	06-1681204
Entity Address, Address Line One	235 Yorkland Blvd., Suite 900
Entity Address, City or Town	Toronto
Entity Address, State or Province	ON
Entity Address, Postal Zip Code	M2J 4Y8
City Area Code	877
Local Phone Number	848-8430
Title of 12(b) Security	Common Stock, $0.0001 par value per share
Trading Symbol	VERO
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		5,526,481

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
CURRENT ASSETS:
Cash and cash equivalents	$ 6,122	$ 11,569
Accounts receivable, net of allowance of $13,233 and $13,619 as of June 30, 2023, and December 31, 2022, respectively	37,520	37,262
Inventories	22,936	23,906
Prepaid expenses	1,481	1,688
Advances to suppliers	5,749	5,881
Other current assets	1,984	3,702
Total current assets	75,792	84,008
LONG-TERM ASSETS:
Long-term trade receivables	12,082	20,044
Deferred tax assets	876	947
Severance pay funds	586	741
Property and equipment, net	1,640	1,857
Operating right-of-use assets, net	4,983	5,862
Intangible assets	10,197	11,919
Total long-term assets	30,364	41,370
TOTAL ASSETS	106,156	125,378
CURRENT LIABILITIES:
Trade payables	8,293	8,033
Accrued expenses and other current liabilities	13,063	16,667
Current portion of long-term debt	7,735	7,735
Income taxes payable	434	117
Unearned interest income	1,915	2,397
Warranty accrual	880	1,074
Deferred revenues	1,050	1,765
Operating lease liabilities	1,571	1,807
Total current liabilities	34,941	39,595
LONG-TERM LIABILITIES:
Long-term debt	70,683	70,003
Income tax payable	385	374
Deferred tax liabilities	6	0
Accrued severance pay	696	867
Unearned interest revenue	552	957
Warranty accrual	377	408
Operating lease liabilities	3,666	4,221
Other long-term liabilities	392	215
Total long-term liabilities	76,757	77,045
TOTAL LIABILITIES	111,698	116,640
Commitments and Contingencies (Note 9)
STOCKHOLDERS’ EQUITY (Note 14):
Common Stock, $0.0001 par value: 300,000,000 shares authorized as of June 30, 2023 and December 31, 2022; 5,526,481 and 5,161,374 issued and outstanding as of June 30, 2023, and December 31, 2022, respectively	30	29
Additional paid-in capital	235,467	232,169
Accumulated deficit	(241,719)	(224,105)
TOTAL STOCKHOLDERS’ EQUITY	(6,222)	8,093
Non-controlling interests	680	645
Equity, Including Portion Attributable to Noncontrolling Interest	(5,542)	8,738
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 106,156	$ 125,378

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Accounts receivable, allowance, current	$ 13,233	$ 13,619
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	300,000,000	300,000,000
Common stock, shares issued (in shares)	5,526,481	5,161,374
Common stock, shares outstanding (in shares)	5,526,481	5,161,374

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Revenue
Revenues	$ 20,075	$ 27,266	$ 40,606	$ 53,672
Cost of goods sold:
Cost of goods and services sold	5,855	8,220	12,687	16,863
Gross profit	14,220	19,046	27,919	36,809
Operating expenses:
Selling and marketing	8,380	10,523	16,412	21,607
General and administrative	9,633	12,937	20,818	24,409
Research and development	1,965	2,712	4,602	5,355
Total operating expenses	19,978	26,172	41,832	51,371
Loss from operations	(5,758)	(7,126)	(13,913)	(14,562)
Other expenses:
Foreign exchange loss (gain)	(178)	2,370	(530)	2,375
Finance expenses	1,553	1,034	3,061	1,957
(Gain) loss on disposal of subsidiaries	(1)	0	76	0
Loss before income taxes	(7,132)	(10,530)	(16,520)	(18,894)
Income tax (benefit) expense	189	(18)	424	254
Net loss	(7,321)	(10,512)	(16,944)	(19,148)
Net loss attributable to stockholders of the Company	(7,409)	(10,559)	(17,066)	(19,178)
Net income attributable to non-controlling interest	$ 88	$ 47	$ 122	$ 30
Net loss per share:
Basic (in dollars per share)	$ (1.35)	$ (2.47)	$ (3.19)	$ (4.49)
Diluted (in dollars per share)	$ (1.35)	$ (2.47)	$ (3.19)	$ (4.49)
Weighted-average number of shares used in per share calculation:
Basic (in shares)	5,471	4,276	5,355	4,271
Diluted (in shares)	5,471	4,276	5,355	4,271
Leases [Member]
Revenue
Revenues	$ 4,311	$ 11,874	$ 10,072	$ 22,297
Cost of goods sold:
Cost of goods and services sold	721	2,761	2,450	5,461
Products and Services [Member]
Revenue
Revenues	15,764	15,392	30,534	31,375
Cost of goods sold:
Cost of goods and services sold	$ 5,134	$ 5,459	$ 10,237	$ 11,402

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Net loss	$ (7,321)	$ (10,512)	$ (16,944)	$ (19,148)
Loss attributable to stockholders of the Company	(7,409)	(10,559)	(17,066)	(19,178)
Income attributable to non-controlling interest	88	47	122	30
Comprehensive loss	$ (7,321)	$ (10,512)	$ (16,944)	$ (19,148)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Preferred Stock [Member] Series A Preferred Stock [Member]	Preferred Stock [Member] The 2022 Private Placement [Member]	Preferred Stock [Member] Multi-Tranche Private Placement 2023 [Member]	Common Stock [Member] Cumulative Effect, Period of Adoption, Adjustment [Member]	Common Stock [Member]	Additional Paid-in Capital [Member] Cumulative Effect, Period of Adoption, Adjustment [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member] Cumulative Effect, Period of Adoption, Adjustment [Member]	Retained Earnings [Member]	Noncontrolling Interest [Member] Cumulative Effect, Period of Adoption, Adjustment [Member]	Noncontrolling Interest [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member]	Total
Balance (in shares) at Dec. 31, 2021	252,717				4,265,506
Balance at Dec. 31, 2021					$ 27		$ 221,321		$ (180,405)		$ 653		$ 41,596
Net income loss — the Company					$ 0		0		(8,619)		0		(8,619)
Income attributable to non-controlling interest							0		0		(17)		(17)
Stock-based compensation							443		0		0		443
Options exercised (in shares)	0				1,098
Options exercised					$ 0		23		0		0		23
Balance (in shares) at Mar. 31, 2022	252,717				4,266,604
Balance at Mar. 31, 2022					$ 27		221,787		(189,024)		636		33,426
Balance (in shares) at Dec. 31, 2021	252,717				4,265,506
Balance at Dec. 31, 2021					$ 27		221,321		(180,405)		653		41,596
Income attributable to non-controlling interest													30
Balance (in shares) at Jun. 30, 2022	252,717				4,293,271
Balance at Jun. 30, 2022					$ 27		222,393		(199,583)		559		23,396
Balance (in shares) at Dec. 31, 2021	252,717				4,265,506
Balance at Dec. 31, 2021					$ 27		221,321		(180,405)		653		41,596
Balance (in shares) at Dec. 31, 2022		3,185,000	0		5,161,374
Balance (Accounting Standards Update 2016-13 [Member]) at Dec. 31, 2022				$ 0		$ 0		$ (548)		$ 0		$ (548)
Balance at Dec. 31, 2022					$ 29		232,169		(224,105)		645		8,738
Balance (in shares) at Mar. 31, 2022	252,717				4,266,604
Balance at Mar. 31, 2022					$ 27		221,787		(189,024)		636		33,426
Issuance of common stock (in shares)	0				26,667
Issuance of common stock					$ 0		48		0		0		48
Net income loss — the Company					0		0		(10,559)		0		(10,559)
Income attributable to non-controlling interest					0		0		0		47		47
Stock-based compensation					0		558		0		0		558
Dividends from subsidiaries					$ 0		0		0		(124)		(124)
Balance (in shares) at Jun. 30, 2022	252,717				4,293,271
Balance at Jun. 30, 2022					$ 27		222,393		(199,583)		559		23,396
Balance (in shares) at Dec. 31, 2022		3,185,000	0		5,161,374
Balance at Dec. 31, 2022					$ 29		232,169		(224,105)		645		8,738
Restricted share units vested (in shares)		0	0		22,000
Restricted share units vested					$ 0		0		0		0		0
Issuance of common stock (in shares)		0	0		224,378
Issuance of common stock					$ 1		744		0		0		745
Net income loss — the Company					0		0		(9,657)		0		(9,657)
Income attributable to non-controlling interest					0		0		0		34		34
Stock-based compensation					$ 0		481		0		0		481
Balance (in shares) at Mar. 31, 2023		3,185,000	0		5,407,752
Balance at Mar. 31, 2023					$ 30		233,394		(234,310)		679		(207)
Balance (in shares) at Dec. 31, 2022		3,185,000	0		5,161,374
Balance (Accounting Standards Update 2016-13 [Member]) at Dec. 31, 2022				$ 0		$ 0		$ (548)		$ 0		$ (548)
Balance at Dec. 31, 2022					$ 29		232,169		(224,105)		645		8,738
Income attributable to non-controlling interest													$ 122
Options exercised (in shares)													0
Balance (in shares) at Jun. 30, 2023		3,185,000	280,899		5,526,481
Balance at Jun. 30, 2023					$ 30		235,467		(241,719)		680		$ (5,542)
Balance (in shares) at Mar. 31, 2023		3,185,000	0		5,407,752
Balance at Mar. 31, 2023					$ 30		233,394		(234,310)		679		(207)
Issuance of common stock (in shares)		0	0		118,729
Issuance of common stock					$ 0		71		0		0		71
Net income loss — the Company			$ 0		0		0		(7,409)		0		(7,409)
Income attributable to non-controlling interest			0		0		0		0		88		88
Stock-based compensation			$ 0		$ 0		369		0		0		369
2023 Private Placement shares, net of costs (in shares)		0	280,899		0
2023 Private Placement shares, net of costs					$ 0		1,206		0		0		1,206
Beneficial conversion feature					0		427		0		0		427
Dividends from subsidiaries			$ 0		$ 0		0		0		(87)		(87)
Balance (in shares) at Jun. 30, 2023		3,185,000	280,899		5,526,481
Balance at Jun. 30, 2023					$ 30		$ 235,467		$ (241,719)		$ 680		$ (5,542)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended		12 Months Ended	18 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Jun. 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (7,321)		$ (10,512)	$ (16,944)	$ (19,148)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization				2,032	2,212
Stock-based compensation				850	1,001
Provision for expected credit losses	358	$ 618		977	3,521	$ 7,337
Provision for inventory obsolescence				674	862
Finance expenses and accretion				680	182
Deferred tax expense (recovery)				78	(283)
Loss on sale of subsidiary				76	0
Loss on disposal of property and equipment				0	31
Changes in operating assets and liabilities:
Accounts receivable short-term and long-term				6,153	(2,492)
Inventories				297	(2,682)
Prepaid expenses				207	568
Advances to suppliers				132	(3,797)
Other current assets				1,642	(115)
Operating right-of-use assets, net				879	6,057
Other long-term assets				(268)	(79)
Trade payables				259	2,361
Accrued expenses and other current liabilities				(4,185)	(1,969)
Current operating lease liabilities				(236)	(1,764)
Severance pay funds				154	2
Unearned interest income				(887)	284
Long-term operating lease liabilities				(555)	(4,293)
Other long-term liabilities				(25)	(172)
Net cash used in operating activities				(8,010)	(19,713)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment				(92)	(251)
Net cash used in investing activities				(92)	(251)
CASH FLOWS FROM FINANCING ACTIVITIES:
2023 Multi-Tranche Private Placement, net of costs of $367				1,633	0
Proceeds from exercise of options				0	23
Proceeds from issuance of common stock				1,109	272
Repayment of government assistance loans				0	(543)
Dividends from subsidiaries paid to non-controlling interest				(87)	(124)
Net cash (used in) provided by financing activities				2,655	(372)
NET DECREASE IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH				(5,447)	(20,336)
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH — Beginning of period		$ 11,569		11,569	30,876	30,876	$ 30,876
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH — End of period	$ 6,122		$ 10,540	6,122	10,540	$ 11,569	$ 6,122
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Cash paid for income taxes				18	224
Cash paid for interest				$ 2,381	$ 1,775

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Cash Flows (Unaudited) (Parentheticals) $ in Thousands	6 Months Ended
	Jun. 30, 2023 USD ($)
Stock issuance costs	$ 367

Note 1 - Nature of Operations

Note 1 - Nature of Operations	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Nature of Operations [Text Block]	1. Venus Concept Inc. is a global medical technology company that develops, commercializes, and sells minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The Company's systems have been designed on cost-effective, proprietary and flexible platforms that enable it to expand beyond the aesthetic industry’s traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family and general practitioners and aesthetic medical spas. The Company was incorporated in the state of Delaware on November 22, 2002. Going Concern The accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business for the foreseeable future, and, as such, the unaudited condensed consolidated financial statements do not The Company has had recurring net operating losses and negative cash flows from operations. As of June 30, 2023 December 31, 2022 a June 30, 2023 December 31, 2022 12 In order to continue its operations, the Company must achieve profitable operations and/or obtain additional equity or debt financing. Until the Company achieves profitability, management plans to fund its operations and capital expenditures with cash on hand, borrowings, and issuance of capital stock. On June 16, 2020, may December 31, 2022 July 2022, July 12, 2022, "2022 2022 2022 2022 June 30, 2023, 2022 2023 14 Stockholders Equity Given the economic uncertainty in U.S. and international markets, the Company cannot anticipate the extent to which the current economic turmoil and financial market conditions will continue to adversely impact the Company’s business and the Company may no may not The accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business for the foreseeable future, and, as such, the unaudited condensed consolidated financial statements do not

Note 2 - Summary of Significant

Note 2 - Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Significant Accounting Policies [Text Block]	2. Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) and with the instructions to Form 10 10 X. not 10 December 31, 2022 March 27, 2023. six June 30, 2023 not may December 31, 2023. 8 10 The preparation of these consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ materially from those estimates. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company as of June 30, 2023 not At the annual and special meeting of the Company’s shareholders held on May 10, 2023, one five 1 one fifteen 1 May 11, 2023, one fifteen 1 May 12, 2023. Amounts reported in thousands within this report are computed based on the amounts in U.S. dollars. As a result, the sum of the components reported in thousands may not may not Accounting Policies The accounting policies the Company follows are set forth in the Company’s audited consolidated financial statements for fiscal year 2022 8 10 no Recently Adopted Accounting Standards In June 2016, 2016 13, 326 Measurement of Credit Losses on Financial Instruments 2018 19, 2019 04, 2019 05, 2019 10, 2019 11, 2020 02, January 1, 2023. Recently Issued Accounting Standards Not In August 2020, No. 2020 06 2020 06” 470 20 815 40 2020 06 2020 06 January 1, 2024, No. 2020 06

Note 3 - Net Loss Per Share

Note 3 - Net Loss Per Share	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Earnings Per Share [Text Block]	3. Net Loss Per Share Basic net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock outstanding during the period, without consideration for common stock equivalents. Diluted net loss per share is computed by dividing net loss by the weighted-average number of common stock equivalents outstanding for the period determined using the treasury-stock method. For purposes of this calculation, common stock warrants and stock options are considered to be common stock equivalents and are only included in the calculation of diluted net loss per share when their effect is dilutive. The following table sets forth the computation of basic and diluted net loss and the weighted average number of shares used in computing basic and diluted net loss per share (in thousands, except per share data): Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Numerator: Net loss $ (7,321 ) $ (10,512 ) $ (16,944 ) $ (19,148 ) Net loss allocated to stockholders of the Company $ (7,409 ) $ (10,559 ) $ (17,066 ) $ (19,178 ) Denominator: Weighted-average shares of common stock outstanding used in computing net loss per share, basic 5,471 4,276 5,355 4,271 Weighted-average shares of common stock outstanding used in computing net loss per share, diluted 5,471 4,276 5,355 4,271 Net loss per share: Basic $ (1.35 ) $ (2.47 ) $ (3.19 ) $ (4.49 ) Diluted $ (1.35 ) $ (2.47 ) $ (3.19 ) $ (4.49 ) Due to the net loss, all the outstanding shares of common stock equivalents were excluded from the calculation of diluted net loss per share attributable to common stockholders for the quarters ended June 30, 2023 2022 June 30, 2023 June 30, 2022 Options to purchase common stock and restricted stock units ("RSUs") 1,019,837 488,255 Preferred stock 2,872,518 252,717 Shares reserved for convertible notes 558,666 547,593 Warrants for common stock 1,061,930 1,061,930 Total potential dilutive shares 5,512,951 2,350,495

Note 4 - Fair Value Measurement

Note 4 - Fair Value Measurements	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Fair Value Disclosures [Text Block]	4. Financial assets and financial liabilities are initially recognized at fair value when the Company becomes a party to the contractual provisions of the financial instrument. Subsequently, all financial instruments are measured at amortized cost using the effective interest method. The financial instruments of the Company consist of cash and cash equivalents, restricted cash, accounts receivable, long-term receivables, lines of credit, trade payables, government assistance loans, accrued expenses and other current liabilities, other long-term liabilities and long-term debt. In view of their nature, the fair value of these financial instruments approximates their carrying amounts. The Company measures the fair value of its financial assets and financial liabilities using the fair value hierarchy. A financial instrument’s classification within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The accounting guidance establishes a three Level 1 Level 2 1 not Level 3 no Guaranteed investment certificates are classified within Level 2 1, 2 3 Fair Value Measurements as of June 30, 2023 Quoted Prices in Active Markets using Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Total Assets Guaranteed Investment Certificates $ — $ 62 $ — $ 62 Total assets $ — $ 62 $ — $ 62 Fair Value Measurements as of December 31, 2022 Quoted Prices in Active Markets using Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Total Assets Guaranteed Investment Certificates $ — $ 59 $ — $ 59 Total assets $ — $ 59 $ — $ 59

Note 5 - Accounts Receivable

Note 5 - Accounts Receivable	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Trade and Financing Receivables [Text Block]	5. The Company’s products may A financing receivable is a contractual right to receive money, on demand or on fixed or determinable dates, that is recognized as an asset on the Company's unaudited condensed consolidated balance sheets. The Company's financing receivables, consisting of sales-type leases, totaled $28,259 and $40,377 as of June 30, 2023 December 31, 2022 The Company performed an assessment of the allowance for expected credit losses as of June 30, 2023 December 31, 2022 June 30, 2023 December 31, 2022 June 30, 2023 326 A summary of the Company’s accounts receivables is presented below: June 30, December 31, 2023 2022 Gross accounts receivable $ 62,835 $ 70,925 Unearned income (2,467 ) (3,354 ) Allowance for expected credit losses (13,233 ) (13,619 ) $ 47,135 $ 53,952 Reported as: Current trade receivables $ 37,520 $ 37,262 Current unearned interest income (1,915 ) (2,397 ) Long-term trade receivables 12,082 20,044 Long-term unearned interest income (552 ) (957 ) $ 47,135 $ 53,952 Current subscription agreements are reported as part of accounts receivable. The following are the contractual commitments, net of allowance for expected credit losses, to be received by the Company over the next 5 June 30, Total 2023 2024 2025 2026 2027 Current financing receivables, net of allowance of $5,475 $ 16,177 $ 16,177 $ — $ — $ — $ — Long-term financing receivables, net of allowance of $536 $ 12,082 $ — $ 10,334 $ 1,734 $ 14 $ — $ 28,259 $ 16,177 $ 10,334 $ 1,734 $ 14 $ — Accounts receivable do not not may The allowance for expected credit losses consisted of the following activity: Balance at January 1, 2022 $ 11,997 Write-offs (5,715 ) Provision 7,337 Balance at December 31, 2022 $ 13,619 Write-offs (30 ) Provision 618 Balance at March 31, 2023 $ 14,207 Write-offs (1,332 ) Provision 358 Balance at June 30, 2023 $ 13,233

Note 6 - Select Balance Sheet a

Note 6 - Select Balance Sheet and Statement of Operations Information	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Balance Sheet and Income Statement Disclosures [Text Block]	6. Inventory Inventory consists of the following: June 30, December 31, 2023 2022 Raw materials $ 2,211 $ 2,478 Work-in-progress 1,596 2,112 Finished goods 19,129 19,316 Total inventory $ 22,936 $ 23,906 Additions to inventory are primarily comprised of newly produced units and applicators, refurbishment cost from demonstration units and used equipment which were reacquired during the period from upgraded sale s. The Company expens in cost of goods sold in the three six June 30, 2023, three six June 30, 2022, The balance of cost of goods sold represents the sale of applicators, parts and warranties. The Company provides for excess and obsolete inventories when conditions indicate that the inventory cost is not June 30, 2023 December 31, 2022 Property and Equipment, Net Property and equipment, net consist of the following: Useful Lives June 30, December 31, (in years) 2023 2022 Lab equipment tooling and molds 4 – 10 $ 3,576 $ 4,356 Office furniture and equipment 6 – 10 1,249 1,240 Leasehold improvements up to 10 621 794 Computers and software 3 934 906 Vehicles 5 – 7 37 37 Demo units 5 214 214 Total property and equipment 6,631 7,547 Less: Accumulated depreciation (4,991 ) (5,690 ) Total property and equipment, net $ 1,640 $ 1,857 Depreciation expense amounted to $144 and $246 for the three June 30, 2023 2022 six June 30, 2023 2022, Other Current Assets June 30, December 31, 2023 2022 Government remittances (1) $ 1,197 $ 1,602 Consideration receivable from subsidiaries sale 231 629 Deferred financing costs 4 301 Sundry assets and miscellaneous 552 1,170 Total other current assets $ 1,984 $ 3,702 ( 1 Accrued Expenses and Other Current Liabilities June 30, December 31, 2023 2022 Payroll and related expense $ 1,601 $ 2,244 Accrued expenses 4,023 5,045 Commission accrual 2,445 3,761 Sales and consumption taxes 4,994 5,617 Total accrued expenses and other current liabilities $ 13,063 $ 16,667 Warranty Accrual The following table provides the details of the change in the Company’s warranty accrual: June 30, December 31, 2023 2022 Balance as of the beginning of the period $ 1,482 $ 1,753 Warranties issued during the period 78 993 Warranty costs incurred during the period (303 ) (1,264 ) Balance at the end of the period $ 1,257 $ 1,482 Current 880 1,074 Long-term 377 408 Total $ 1,257 $ 1,482 Finance Expenses The following table provides the details of the Company’s finance expenses: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Interest expense $ 1,487 $ 969 $ 2,930 $ 1,827 Accretion on long-term debt and amortization of fees 66 65 131 130 Total finance expenses $ 1,553 $ 1,034 $ 3,061 $ 1,957

Note 7 - Leases

Note 7 - Leases	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Lessee, Operating Leases [Text Block]	7. LEASES The following presents the various components of lease costs. Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Operating lease cost $ 503 $ 607 $ 1,013 $ 941 Short-term lease cost — — — — Total lease cost $ 503 $ 607 $ 1,013 $ 941 The following table presents supplemental information relating to the cash flows arising from lease transactions. Cash payments related to short-term leases are not Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Operating cash outflows from operating leases $ 503 $ 607 $ 1,013 $ 941 The following table presents the weighted-average lease term and discount rate for operating leases. At June 30, 2023 2022 Operating leases Weighted-average remaining lease term (in years) 3.44 4.29 Weighted-average discount rate 4.00 % 4.00 % The following table presents a maturity analysis of expected undiscounted cash flows for operating leases on an annual basis for the next five Years ending December 31, Operating leases 2023 $ 780 2024 1,407 2025 1,228 2026 1,039 2027 594 Thereafter 544 Imputed Interest (1) (355 ) Total $ 5,237 ( 1

Note 8 - Intangible Assets

Note 8 - Intangible Assets	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Goodwill and Intangible Assets Disclosure [Text Block]	8. Intangible assets net of accumulated amortization and goodwill were as follows: At June 30, 2023 Gross Amount Accumulated Amortization Net Amount Customer relationships $ 1,400 $ (475 ) $ 925 Brand 2,500 (1,197 ) 1,303 Technology 16,900 (10,317 ) 6,583 Supplier agreement 3,000 (1,614 ) 1,386 Total intangible assets $ 23,800 $ (13,603 ) $ 10,197 At December 31, 2022 Gross Amount Accumulated Amortization Net Amount Customer relationships $ 1,400 $ (429 ) $ 971 Brand 2,500 (1,066 ) 1,434 Technology 16,900 (8,919 ) 7,981 Supplier agreement 3,000 (1,467 ) 1,533 Total intangible assets $ 23,800 $ (11,881 ) $ 11,919 For the three June 30, 2023 2022 $865, six June 30, 2023 2022, Estimated amortization expense for the next five Years ending December 31, 2023 $ 1,751 2024 3,473 2025 3,004 2026 656 2027 657 Thereafter 656 Total $ 10,197

Note 9 - Commitments and Contin

Note 9 - Commitments and Contingencies	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	9. Commitments As of June 30, 2023 June 30, 2023 270 Aggregate future service and purchase commitments with manufacturers as of June 30, 2023 Years ending December 31, Purchase and Service Commitments 2023 $ 15,086 2024 and Thereafter — Total $ 15,086 Legal Proceedings Purported Shareholder Class Actions On July 11, 2019, No. 5:19 03997 14 2018 August 21, 2019, June 21, 2021, March 2, 2023, not

Note 10 - Main Street Term Loan

Note 10 - Main Street Term Loan	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Debt Disclosure [Text Block]	10. On December 8, 2020, 13 3 December 9, 2020, five 30 December 8, 2023 December 8, 2024, fifteen December 8, 2025. may As of June 30, 2023 December 31, 2022 The scheduled payments on the outstanding borrowings as of June 30, 2023 As of June 30, 2023 2023 $ 9,889 2024 10,239 2025 40,365 Total $ 60,493

Note 11 - Madryn Long-term Debt

Note 11 - Madryn Long-term Debt and Convertible Notes	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Debt Disclosure [Text Block]	10. On December 8, 2020, 13 3 December 9, 2020, five 30 December 8, 2023 December 8, 2024, fifteen December 8, 2025. may As of June 30, 2023 December 31, 2022 The scheduled payments on the outstanding borrowings as of June 30, 2023 As of June 30, 2023 2023 $ 9,889 2024 10,239 2025 40,365 Total $ 60,493
Madryn Long Term Debt and Convertible Notes [Member]
Notes to Financial Statements
Debt Disclosure [Text Block]	11. On October 11, 2016, On December 9, 2020, 10 December 8, 2020, December 9, 2020, December 9, 2020, December 9, 2020 As of June 30, 2023, The Notes will accrue interest at a rate of 8.0% per annum from the date of original issuance of the Notes to the third December 31, 2020. December 9, 2025 December 9, 2020 ( December 9, 2020 ( first not 10 12 three June 30, 2023 2022, six June 30, 2023 2022 815 10 15 not 815, two June 30, 2023 December 31, 2022 June 30, 2023 December 31, 2022 The scheduled payments on the outstanding borrowings as of June 30, 2023 As of June 30, 2023 2023 $ 1,608 2024 1,628 2025 28,217 Total $ 31,453 For the three six June 30, 2023 not June 30, 2023 July 28, 2023, Q2 2023 June 30, 2023 Q2 2023 Q2 2023 August 15, 2023 may

Note 12 - Credit Facility

Note 12 - Credit Facility	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Credit Facility Disclosure [Text Block]	12. CREDIT FACILITY On August 29, 2018, March 20, 2020, December 9, 2020 August 26, 2021 ( August 29, 2018, March 20, 2020, December 9, 2020 August 26, 2021 ( March 20, 2020, December 9, 2020 August 26, 2021, The CNB Loan Agreement contains various covenants that limit the Company’s ability to engage in specified types of transactions. Subject to limited exceptions, these covenants limit the Company’s ability, without CNB’s consent, to, among other things, sell, lease, transfer, exclusively license or dispose of the Company’s assets, incur, create, or permit to exist additional indebtedness, or liens, to make dividends and certain other restricted payments, and to make certain changes to its management and/or ownership structure. The Company is required to maintain $3,000 in cash in a deposit account maintained with CNB at all times during the term of the CNB Loan Agreement. In addition, the CNB Loan Agreement contains certain covenants that require the Company to achieve certain minimum account balances, or a minimum debt service coverage ratio and a maximum total liability to tangible net worth ratio. If the Company fails to comply with these covenants, it will result in a default and require the Company to repay all outstanding principal amounts and any accrued interest. In connection with the CNB Loan Agreement, a loan fee of $1,000 was paid in equal installments on January 25, February 25, March 25, 2021. On August 26, 2021, 30 December 10, 2021, February 22, 2023, 2 not As of June 30, 2023 December 31, 2022 10 In connection with the Amended CNB Loan Agreement, the Company, Venus USA and Venus Canada issued a promissory note dated August 26, 2021, July 24, 2023 August 26, 2021

Note 13 - Common Stock Reserved

Note 13 - Common Stock Reserved for Issuance	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Common Stock Reserved For Issuance [Text Block]	13. The Company is required to reserve and keep available out of its authorized but unissued shares of common stock a number of shares sufficient to affect the exercise of all options granted and available for grant under the incentive plans and warrants to purchase common stock. June 30, 2023 December 31, 2022 Outstanding common stock warrants 1,061,930 1,061,930 Outstanding stock options and RSUs 1,019,837 875,524 Preferred shares 2,872,518 2,123,443 Shares reserved for conversion of future non-voting preferred share issuance — 80,617 Shares reserved for conversion of future voting preferred share issuance 7,860,916 609,891 Shares reserved for future option grants and RSUs 64,292 24,999 Shares reserved for Lincoln Park 711,180 1,054,299 Shares reserved for Madryn Noteholders 558,666 547,714 Total common stock reserved for issuance 14,149,339 6,378,417

Note 14 - Stockholders Equity

Note 14 - Stockholders Equity	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Equity [Text Block]	14. Common Stock The Company’s common stock confers upon its holders the following rights: • The right to participate and vote in the Company’s stockholder meetings, whether annual or special. Each share will entitle its holder, when attending and participating in the voting in person or via proxy, to one • The right to a share in the distribution of dividends, whether in cash or in the form of bonus shares, the distribution of assets or any other distribution pro rata to the par value of the shares held by them; and • The right to a share in the distribution of the Company’s excess assets upon liquidation pro rata to the par value of the shares held by them. Reverse Stock Split At the annual and special meeting of the Company’s shareholders held on May 10, 2023, one five 1 one fifteen 1 May 11, 2023, one fifteen 1 May 12, 2023. Equity Purchase Agreement with Lincoln Park On June 16, 2020, may may no no 5635 no may From commencement to expiry on July 1, 2022, 2022, December 31, 2022 July 1, 2022, 2022 2022 On July 12, 2022, 2022 July 1, 2022. 2022 may 2022 “2022 2022 2022 may not 2022 “2022 2022 2022 no 2022 2022 five 2022 2022 2022 2022 may not 2022 2022 2022 December 31, 2022, six June 30, 2023, 2022 8 July 12, 2022. The 2021 On December 15, 2021, "2021 2021 "2021 2021 2021 2021 2022 Preferred Stock issued in December 2021 As noted above, in December 2021, 2021 December 14, 2021. May 15, 2023, 10 December 31, 2022 The 2022 November 2022, “2022 2022 2022 30 "2022 2022 November 18, 2022. 2022 2022 2022 2022 8 November 18, 2022. Voting Preferred Stock issued in November 2022 As noted above, in November 2022, 2022 November 17, 2022. • Voting Rights. • Liquidation. • Conversion one 2022 30 30 two • Dividends. • Redemption not • Maturity. The 2023 In May 2023, "2023 "2023 may 2023 "2023 December 31, 2025, 2023 May 15, 2023, 2023 • Voting Rights. no two not not • Liquidation. • Conversion one 30 30 • Dividends. • Redemption not • Maturity. 2010 In November 2010, “2010 2010 seven ten November 2017 2010 not June 30, 2023 2010 December 31, 2022 2019 Incentive Award Plan The 2019 “2019 2017 September 12, 2017 September 14, 2017. 2017 October 4, 2019. Under the 2019 2019 June 30, 2023 2019 December 31, 2022 2019 first 2020 2029 four The Company recognized stock-based compensation for its employees and non-employees in the accompanying unaudited condensed consolidated statements of operations as follows: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Cost of sales $ 11 $ 13 $ 26 $ 21 Selling and marketing 76 134 185 309 General and administrative 251 322 551 551 Research and development 31 89 88 120 Total stock-based compensation $ 369 $ 558 $ 850 $ 1,001 Stock Options The fair value of each option is estimated at the date of grant using the Black-Scholes option pricing formula with the following assumptions : Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Expected term (in years) 6.00 6.00 6.00 6.00 Risk-free interest rate 3.37 % 2.92 % 3.37 3.41 % 2.56 2.92 % Expected volatility 42.72 % 42.89 % 42.98 % 42.56 % Expected dividend rate 0 % 0 % 0 % 0 % Expected Term Volatility not Risk-Free Interest Rate zero Dividend Rate not Fair Value of Common Stock The following table summarizes stock option activity under the Company’s stock option plans: Number of Shares Weighted- Average Exercise Price per Share, $ Weighted- Average Remaining Contractual Term Aggregate Intrinsic Value Outstanding – January 1, 2023 849,600 $ 25.05 8.23 $ 209 Options granted 211,031 2.89 - — Options exercised - - - — Options forfeited/cancelled (43,462 ) 35.07 - — Outstanding – June 30, 2023 1,017,169 20.05 7.92 $ — Exercisable – June 30, 2023 276,841 48.22 5.26 $ — Expected to vest – after June 30, 2023 740,328 $ 9.51 8.91 $ — The following tables summarize information about stock options outstanding and exercisable at June 30, 2023 Options Outstanding Options Exercisable Exercise Price Range Number Weighted average remaining contractual term (years) Weighted average Exercise Price Options exercisable Weighted average remaining contractual term (years) Weighted average Exercise Price $2.82 - $54.60 967,750 8.12 $ 15.19 228,587 5.55 $ 33.94 $63.90 - $119.25 46,638 3.92 99.45 45,473 3.85 99.76 $186.75 - $382.50 1,630 5.24 271.36 1,630 5.24 271.36 $405.00 - $438.75 644 1.79 405.21 644 1.79 405.21 $540.00 - $958.50 507 4.44 691.99 507 4.44 691.99 1,017,169 7.92 $ 20.05 276,841 5.26 $ 48.22 The aggregate intrinsic value of options is calculated as the difference between the exercise price of the stock options and the fair value of the Company’s common stock for those options that had exercise prices lower than the fair value of the Company’s common stock. The total intrinsic value of options exercised were $nil $nil three June 30, 2023 2022, $nil $nil six June 30, 2023 2022, The weighted-average grant date fair value of options granted was $3.38 three June 30, 2023 2022, six June 30, 2023 2022, three June 30, 2023 2022 six June 30, 2023 2022 Restricted Stock Units The following table summarizes information about RSUs outstanding at June 30, 2023 Number of Shares Weighted- Average Grant Date Fair Value per Share, $ Outstanding – January 1, 2023 25,918 $ 19.50 RSUs granted — — RSUs forfeited/cancelled (1,250 ) 20.70 RSUs exercised (22,000 ) 20.70 Outstanding - June 30, 2023 2,668 $ 8.70

Note 15 - Income Taxes

Note 15 - Income Taxes	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Income Tax Disclosure [Text Block]	15. The Company generated a loss and recognize d $189 of tax expense for the three June 30, 2023 , and $18 of tax benefit for the three June 30, 2022 , respectively. The Company generated a loss and recognized $424 of tax expense for the six June 30, 2023, six June 30, 2022, A reconciliation of income tax (benefit) expense is as follows: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Loss before income taxes $ (7,132 ) $ (10,530 ) $ (16,520 ) $ (18,894 ) Theoretical tax expense at the statutory rate ( 21 (1,484 ) (2,211 ) (3,456 ) (3,968 ) Differences in jurisdictional tax rates (281 ) (341 ) (548 ) (593 ) Valuation allowance 1,890 2,118 4,332 4,185 Non-deductible expenses 65 418 97 631 Other (1 ) (2 ) (1 ) (1 ) Total income tax provision (recovery) 189 (18 ) 424 254 Net loss $ (7,321 ) $ (10,512 ) $ (16,944 ) $ (19,148 ) Income tax expense or benefit is recognized based on the actual loss incurred during the three six June 30, 2023 2022

Note 16 - Segment and Geographi

Note 16 - Segment and Geographic Information	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	16. Operating segments are defined as components of an entity for which separate financial information is available and that is regularly reviewed by the Chief Operating Decision Maker (“CODM”) in deciding how to allocate resources to an individual segment and in assessing performance. The Company's CODM is its Chief Executive Officer. The Company has determined it operates in a single operating segment and has one not Revenue by geographic location, which is based on the product shipped to location, is summarized as follows: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 United States $ 9,757 $ 13,417 $ 20,498 $ 26,546 International 10,318 13,849 20,108 27,126 Total revenue $ 20,075 $ 27,266 $ 40,606 $ 53,672 As of June 30, 2023 were located in the United States and $1,275 December 31, 2022 Revenue by type is a key indicator for providing management with an understanding of the Company’s financial performance, which is organized into four 1. 2. 3. 4. The following table presents revenue by type: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Lease revenue $ 4,311 $ 11,874 $ 10,072 $ 22,297 System revenue 12,313 11,548 23,377 23,422 Product revenue 2,586 3,080 5,532 6,577 Service revenue 865 764 1,625 1,376 Total revenue $ 20,075 $ 27,266 $ 40,606 $ 53,672

Note 17 - Related Party Transac

Note 17 - Related Party Transactions	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	17. All amounts were recorded at the exchange amount, which is the amount established and agreed to by the related parties. The following are transactions between the Company and parties related through employment. Distribution agreements On January 1, 2018, three June 30, 2023 2022 t of $114 and $329, respectively, under this distribution agreement. These sales are included in products and services revenue. For the six June 30, 2023 2022, In 2020, January 1, 2021, will continue to distribute the Company’s products in Singapore. A former senior officer of the Company is a 45.0% shareholder of Aexel Biomed. During the three June 30, 2023 2022 , Aexel Biomed purchased products in the amount of $62 and $141, respectively, under the distribution agreement. During the six June 30, 2023 2022, These sales are included in products and services revenue.

Note 18 - Subsequent Events

Note 18 - Subsequent Events	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Subsequent Events [Text Block]	18. On July 6, 2023, 2023 2023 5635 2023 2023 On July 12, 2023, 2023 second 2023 2023

Significant Accounting Policies

Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2023
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) and with the instructions to Form 10 10 X. not 10 December 31, 2022 March 27, 2023. six June 30, 2023 not may December 31, 2023. 8 10 The preparation of these consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ materially from those estimates. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company as of June 30, 2023 not At the annual and special meeting of the Company’s shareholders held on May 10, 2023, one five 1 one fifteen 1 May 11, 2023, one fifteen 1 May 12, 2023. Amounts reported in thousands within this report are computed based on the amounts in U.S. dollars. As a result, the sum of the components reported in thousands may not may not
Accounting Policies [Policy Text Block]	Accounting Policies The accounting policies the Company follows are set forth in the Company’s audited consolidated financial statements for fiscal year 2022 8 10 no
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Adopted Accounting Standards In June 2016, 2016 13, 326 Measurement of Credit Losses on Financial Instruments 2018 19, 2019 04, 2019 05, 2019 10, 2019 11, 2020 02, January 1, 2023. Recently Issued Accounting Standards Not In August 2020, No. 2020 06 2020 06” 470 20 815 40 2020 06 2020 06 January 1, 2024, No. 2020 06

Note 3 - Net Loss Per Share (Ta

Note 3 - Net Loss Per Share (Tables)	6 Months Ended
	Jun. 30, 2023
Notes Tables
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Numerator: Net loss $ (7,321 ) $ (10,512 ) $ (16,944 ) $ (19,148 ) Net loss allocated to stockholders of the Company $ (7,409 ) $ (10,559 ) $ (17,066 ) $ (19,178 ) Denominator: Weighted-average shares of common stock outstanding used in computing net loss per share, basic 5,471 4,276 5,355 4,271 Weighted-average shares of common stock outstanding used in computing net loss per share, diluted 5,471 4,276 5,355 4,271 Net loss per share: Basic $ (1.35 ) $ (2.47 ) $ (3.19 ) $ (4.49 ) Diluted $ (1.35 ) $ (2.47 ) $ (3.19 ) $ (4.49 )
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	June 30, 2023 June 30, 2022 Options to purchase common stock and restricted stock units ("RSUs") 1,019,837 488,255 Preferred stock 2,872,518 252,717 Shares reserved for convertible notes 558,666 547,593 Warrants for common stock 1,061,930 1,061,930 Total potential dilutive shares 5,512,951 2,350,495

Note 4 - Fair Value Measureme_2

Note 4 - Fair Value Measurements (Tables)	6 Months Ended
	Jun. 30, 2023
Notes Tables
Fair Value, by Balance Sheet Grouping [Table Text Block]	Fair Value Measurements as of June 30, 2023 Quoted Prices in Active Markets using Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Total Assets Guaranteed Investment Certificates $ — $ 62 $ — $ 62 Total assets $ — $ 62 $ — $ 62 Fair Value Measurements as of December 31, 2022 Quoted Prices in Active Markets using Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Total Assets Guaranteed Investment Certificates $ — $ 59 $ — $ 59 Total assets $ — $ 59 $ — $ 59

Note 5 - Accounts Receivable (T

Note 5 - Accounts Receivable (Tables)	6 Months Ended
	Jun. 30, 2023
Notes Tables
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]	June 30, December 31, 2023 2022 Gross accounts receivable $ 62,835 $ 70,925 Unearned income (2,467 ) (3,354 ) Allowance for expected credit losses (13,233 ) (13,619 ) $ 47,135 $ 53,952 Reported as: Current trade receivables $ 37,520 $ 37,262 Current unearned interest income (1,915 ) (2,397 ) Long-term trade receivables 12,082 20,044 Long-term unearned interest income (552 ) (957 ) $ 47,135 $ 53,952
Contractual Commitments, Net of Allowance For Doubtful Accounts To Be Received Maturity [Table Text Block]	June 30, Total 2023 2024 2025 2026 2027 Current financing receivables, net of allowance of $5,475 $ 16,177 $ 16,177 $ — $ — $ — $ — Long-term financing receivables, net of allowance of $536 $ 12,082 $ — $ 10,334 $ 1,734 $ 14 $ — $ 28,259 $ 16,177 $ 10,334 $ 1,734 $ 14 $ —
Accounts Receivable, Allowance for Credit Loss [Table Text Block]	Balance at January 1, 2022 $ 11,997 Write-offs (5,715 ) Provision 7,337 Balance at December 31, 2022 $ 13,619 Write-offs (30 ) Provision 618 Balance at March 31, 2023 $ 14,207 Write-offs (1,332 ) Provision 358 Balance at June 30, 2023 $ 13,233

Note 6 - Select Balance Sheet_2

Note 6 - Select Balance Sheet and Statement of Operations Information (Tables)	6 Months Ended
	Jun. 30, 2023
Notes Tables
Schedule of Inventory, Current [Table Text Block]	June 30, December 31, 2023 2022 Raw materials $ 2,211 $ 2,478 Work-in-progress 1,596 2,112 Finished goods 19,129 19,316 Total inventory $ 22,936 $ 23,906
Property, Plant and Equipment [Table Text Block]	Useful Lives June 30, December 31, (in years) 2023 2022 Lab equipment tooling and molds 4 – 10 $ 3,576 $ 4,356 Office furniture and equipment 6 – 10 1,249 1,240 Leasehold improvements up to 10 621 794 Computers and software 3 934 906 Vehicles 5 – 7 37 37 Demo units 5 214 214 Total property and equipment 6,631 7,547 Less: Accumulated depreciation (4,991 ) (5,690 ) Total property and equipment, net $ 1,640 $ 1,857
Schedule of Other Current Assets [Table Text Block]	June 30, December 31, 2023 2022 Government remittances (1) $ 1,197 $ 1,602 Consideration receivable from subsidiaries sale 231 629 Deferred financing costs 4 301 Sundry assets and miscellaneous 552 1,170 Total other current assets $ 1,984 $ 3,702
Schedule of Accrued Expenses and Other Current Liabilities [Table Text Block]	June 30, December 31, 2023 2022 Payroll and related expense $ 1,601 $ 2,244 Accrued expenses 4,023 5,045 Commission accrual 2,445 3,761 Sales and consumption taxes 4,994 5,617 Total accrued expenses and other current liabilities $ 13,063 $ 16,667
Schedule of Product Warranty Liability [Table Text Block]	June 30, December 31, 2023 2022 Balance as of the beginning of the period $ 1,482 $ 1,753 Warranties issued during the period 78 993 Warranty costs incurred during the period (303 ) (1,264 ) Balance at the end of the period $ 1,257 $ 1,482 Current 880 1,074 Long-term 377 408 Total $ 1,257 $ 1,482
Schedule of Finance Expenses [Table Text Block]	Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Interest expense $ 1,487 $ 969 $ 2,930 $ 1,827 Accretion on long-term debt and amortization of fees 66 65 131 130 Total finance expenses $ 1,553 $ 1,034 $ 3,061 $ 1,957

Note 7 - Leases (Tables)

Note 7 - Leases (Tables)	6 Months Ended
	Jun. 30, 2023
Notes Tables
Lease, Cost [Table Text Block]	Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Operating lease cost $ 503 $ 607 $ 1,013 $ 941 Short-term lease cost — — — — Total lease cost $ 503 $ 607 $ 1,013 $ 941 Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Operating cash outflows from operating leases $ 503 $ 607 $ 1,013 $ 941 At June 30, 2023 2022 Operating leases Weighted-average remaining lease term (in years) 3.44 4.29 Weighted-average discount rate 4.00 % 4.00 %
Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]	Years ending December 31, Operating leases 2023 $ 780 2024 1,407 2025 1,228 2026 1,039 2027 594 Thereafter 544 Imputed Interest (1) (355 ) Total $ 5,237

Note 8 - Intangible Assets (Tab

Note 8 - Intangible Assets (Tables)	6 Months Ended
	Jun. 30, 2023
Notes Tables
Schedule of Intangible Assets and Goodwill [Table Text Block]	At June 30, 2023 Gross Amount Accumulated Amortization Net Amount Customer relationships $ 1,400 $ (475 ) $ 925 Brand 2,500 (1,197 ) 1,303 Technology 16,900 (10,317 ) 6,583 Supplier agreement 3,000 (1,614 ) 1,386 Total intangible assets $ 23,800 $ (13,603 ) $ 10,197 At December 31, 2022 Gross Amount Accumulated Amortization Net Amount Customer relationships $ 1,400 $ (429 ) $ 971 Brand 2,500 (1,066 ) 1,434 Technology 16,900 (8,919 ) 7,981 Supplier agreement 3,000 (1,467 ) 1,533 Total intangible assets $ 23,800 $ (11,881 ) $ 11,919
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	Years ending December 31, 2023 $ 1,751 2024 3,473 2025 3,004 2026 656 2027 657 Thereafter 656 Total $ 10,197

Note 9 - Commitments and Cont_2

Note 9 - Commitments and Contingencies (Tables)	6 Months Ended
	Jun. 30, 2023
Notes Tables
Contractual Obligation, Fiscal Year Maturity [Table Text Block]	Years ending December 31, Purchase and Service Commitments 2023 $ 15,086 2024 and Thereafter — Total $ 15,086

Note 10 - Main Street Term Lo_2

Note 10 - Main Street Term Loan (Tables)	6 Months Ended
	Jun. 30, 2023
MSLP Note [Member]
Notes Tables
Schedule of Maturities of Long-Term Debt [Table Text Block]	As of June 30, 2023 2023 $ 9,889 2024 10,239 2025 40,365 Total $ 60,493

Note 11 - Madryn Long-term De_2

Note 11 - Madryn Long-term Debt and Convertible Notes (Tables)	6 Months Ended
	Jun. 30, 2023
Secured Subordinated Convertible Notes [Member]
Notes Tables
Schedule of Maturities of Long-Term Debt [Table Text Block]	As of June 30, 2023 2023 $ 1,608 2024 1,628 2025 28,217 Total $ 31,453

Note 13 - Common Stock Reserv_2

Note 13 - Common Stock Reserved for Issuance (Tables)	6 Months Ended
	Jun. 30, 2023
Notes Tables
Schedule of Common Stock Reserved for Issuance [Table Text Block]	June 30, 2023 December 31, 2022 Outstanding common stock warrants 1,061,930 1,061,930 Outstanding stock options and RSUs 1,019,837 875,524 Preferred shares 2,872,518 2,123,443 Shares reserved for conversion of future non-voting preferred share issuance — 80,617 Shares reserved for conversion of future voting preferred share issuance 7,860,916 609,891 Shares reserved for future option grants and RSUs 64,292 24,999 Shares reserved for Lincoln Park 711,180 1,054,299 Shares reserved for Madryn Noteholders 558,666 547,714 Total common stock reserved for issuance 14,149,339 6,378,417

Note 14 - Stockholders Equity (

Note 14 - Stockholders Equity (Tables)	6 Months Ended
	Jun. 30, 2023
Notes Tables
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]	Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Cost of sales $ 11 $ 13 $ 26 $ 21 Selling and marketing 76 134 185 309 General and administrative 251 322 551 551 Research and development 31 89 88 120 Total stock-based compensation $ 369 $ 558 $ 850 $ 1,001
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Expected term (in years) 6.00 6.00 6.00 6.00 Risk-free interest rate 3.37 % 2.92 % 3.37 3.41 % 2.56 2.92 % Expected volatility 42.72 % 42.89 % 42.98 % 42.56 % Expected dividend rate 0 % 0 % 0 % 0 %
Share-Based Payment Arrangement, Option, Activity [Table Text Block]	Number of Shares Weighted- Average Exercise Price per Share, $ Weighted- Average Remaining Contractual Term Aggregate Intrinsic Value Outstanding – January 1, 2023 849,600 $ 25.05 8.23 $ 209 Options granted 211,031 2.89 - — Options exercised - - - — Options forfeited/cancelled (43,462 ) 35.07 - — Outstanding – June 30, 2023 1,017,169 20.05 7.92 $ — Exercisable – June 30, 2023 276,841 48.22 5.26 $ — Expected to vest – after June 30, 2023 740,328 $ 9.51 8.91 $ —
Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]	Options Outstanding Options Exercisable Exercise Price Range Number Weighted average remaining contractual term (years) Weighted average Exercise Price Options exercisable Weighted average remaining contractual term (years) Weighted average Exercise Price $2.82 - $54.60 967,750 8.12 $ 15.19 228,587 5.55 $ 33.94 $63.90 - $119.25 46,638 3.92 99.45 45,473 3.85 99.76 $186.75 - $382.50 1,630 5.24 271.36 1,630 5.24 271.36 $405.00 - $438.75 644 1.79 405.21 644 1.79 405.21 $540.00 - $958.50 507 4.44 691.99 507 4.44 691.99 1,017,169 7.92 $ 20.05 276,841 5.26 $ 48.22
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]	Number of Shares Weighted- Average Grant Date Fair Value per Share, $ Outstanding – January 1, 2023 25,918 $ 19.50 RSUs granted — — RSUs forfeited/cancelled (1,250 ) 20.70 RSUs exercised (22,000 ) 20.70 Outstanding - June 30, 2023 2,668 $ 8.70

Note 15 - Income Taxes (Tables)

Note 15 - Income Taxes (Tables)	6 Months Ended
	Jun. 30, 2023
Notes Tables
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Loss before income taxes $ (7,132 ) $ (10,530 ) $ (16,520 ) $ (18,894 ) Theoretical tax expense at the statutory rate ( 21 (1,484 ) (2,211 ) (3,456 ) (3,968 ) Differences in jurisdictional tax rates (281 ) (341 ) (548 ) (593 ) Valuation allowance 1,890 2,118 4,332 4,185 Non-deductible expenses 65 418 97 631 Other (1 ) (2 ) (1 ) (1 ) Total income tax provision (recovery) 189 (18 ) 424 254 Net loss $ (7,321 ) $ (10,512 ) $ (16,944 ) $ (19,148 )

Note 16 - Segment and Geograp_2

Note 16 - Segment and Geographic Information (Tables)	6 Months Ended
	Jun. 30, 2023
Notes Tables
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]	Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 United States $ 9,757 $ 13,417 $ 20,498 $ 26,546 International 10,318 13,849 20,108 27,126 Total revenue $ 20,075 $ 27,266 $ 40,606 $ 53,672
Revenue from External Customers by Products and Services [Table Text Block]	Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Lease revenue $ 4,311 $ 11,874 $ 10,072 $ 22,297 System revenue 12,313 11,548 23,377 23,422 Product revenue 2,586 3,080 5,532 6,577 Service revenue 865 764 1,625 1,376 Total revenue $ 20,075 $ 27,266 $ 40,606 $ 53,672

Note 1 - Nature of Operations (

Note 1 - Nature of Operations (Details Textual) - USD ($) $ / shares in Units, $ in Thousands		1 Months Ended	3 Months Ended			6 Months Ended		12 Months Ended		18 Months Ended	36 Months Ended
	Jul. 12, 2022	Jul. 31, 2022	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Dec. 31, 2022	Jun. 30, 2023	Jun. 30, 2023	Jul. 13, 2021	Jun. 16, 2020
Retained Earnings (Accumulated Deficit)			$ (241,719)			$ (241,719)		$ (241,719)	$ (224,105)	$ (241,719)	$ (241,719)
Proceeds from Issuance of Common Stock						$ 1,109	$ 272
Stock Issued During Period, Value, New Issues			$ 71	$ 745	$ 48
Equity Purchase Agreement [Member] | Lincoln Park [Member]
Equity Purchase Agreement, Maximum Offering Amount													$ 31,000
Stock Issued During Period, Shares, New Issues (in shares)		20,000							26,666,000		229,139
Proceeds from Issuance of Common Stock		$ 300							$ 272
Shares Issued, Price Per Share (in dollars per share)			$ 40.50			$ 40.50		$ 40.50		$ 40.50	$ 40.50
LPC Purchase Agreement 2022 [Member] | Lincoln Park [Member]
Equity Purchase Agreement, Maximum Offering Amount	$ 11,000
Stock Issued During Period, Shares, New Issues (in shares)	50,000					343,116		780,000	433,336
Proceeds from Issuance of Common Stock										$ 8,700
Stock Issued During Period, Value, New Issues	$ 300					$ 1,109		$ 3,100	$ 1,970
Shares Issued, Price Per Share (in dollars per share)			$ 3.23			$ 3.23		$ 3.23	$ 4.54	$ 3.23	$ 3.23	$ 3.97

Note 2 - Summary of Significa_2

Note 2 - Summary of Significant Accounting Policies (Details Textual) $ in Thousands	May 11, 2023	May 11, 2023	May 10, 2023	Jun. 30, 2023 USD ($)	Jan. 01, 2023 USD ($)	Dec. 31, 2022 USD ($)
Retained Earnings (Accumulated Deficit)				$ (241,719)		$ (224,105)
Accounting Standards Update 2016-13 [Member] | Cumulative Effect, Period of Adoption, Adjustment [Member]
Retained Earnings (Accumulated Deficit)					$ (500)
Reverse Stock Split [Member]
Stockholders' Equity Note, Stock Split, Conversion Ratio	15	15
Reverse Stock Split [Member] | Minimum [Member]
Stockholders' Equity Note, Stock Split, Conversion Ratio			5
Reverse Stock Split [Member] | Maximum [Member]
Stockholders' Equity Note, Stock Split, Conversion Ratio			15

Note 3 - Net Loss Per Share - C

Note 3 - Net Loss Per Share - Computation of Basic and Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Net loss	$ (7,321)	$ (10,512)	$ (16,944)	$ (19,148)
Loss attributable to stockholders of the Company	$ (7,409)	$ (10,559)	$ (17,066)	$ (19,178)
Weighted-average shares of common stock outstanding used in computing net loss per share, basic (in shares)	5,471	4,276	5,355	4,271
Weighted-average shares of common stock outstanding used in computing net loss per share, diluted (in shares)	5,471	4,276	5,355	4,271
Basic (in dollars per share)	$ (1.35)	$ (2.47)	$ (3.19)	$ (4.49)
Diluted (in dollars per share)	$ (1.35)	$ (2.47)	$ (3.19)	$ (4.49)

Note 3 - Net Loss Per Share - A

Note 3 - Net Loss Per Share - Antidilutive Securities (Details) - shares	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Total potential dilutive shares (in shares)	5,512,951	2,350,495
Share-Based Payment Arrangement, Option [Member]
Total potential dilutive shares (in shares)	1,019,837	488,255
Performance Shares [Member]
Total potential dilutive shares (in shares)	2,872,518	252,717
Shares Reserved for Convertible Notes [Member]
Total potential dilutive shares (in shares)	558,666	547,593
Warrant [Member]
Total potential dilutive shares (in shares)	1,061,930	1,061,930

Note 4 - Fair Value Measureme_3

Note 4 - Fair Value Measurements - Fair Value Measurements (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Assets, fair value	$ 62	$ 59
Guaranteed Investment Certificates [Member]
Assets, fair value	62	59
Fair Value, Inputs, Level 1 [Member]
Assets, fair value	0	0
Fair Value, Inputs, Level 1 [Member] | Guaranteed Investment Certificates [Member]
Assets, fair value	0	0
Fair Value, Inputs, Level 2 [Member]
Assets, fair value	62	59
Fair Value, Inputs, Level 2 [Member] | Guaranteed Investment Certificates [Member]
Assets, fair value	62	59
Fair Value, Inputs, Level 3 [Member]
Assets, fair value	0	0
Fair Value, Inputs, Level 3 [Member] | Guaranteed Investment Certificates [Member]
Assets, fair value	$ 0	$ 0

Note 5 - Accounts Receivable (D

Note 5 - Accounts Receivable (Details Textual) - USD ($) $ in Thousands	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Lessor, Sales-type Lease, Term of Contract (Month)	36 months
Sales-type and Direct Financing Leases, Lease Receivable	$ 28,259		$ 40,377
Accounts Receivable, Allowance for Credit Loss	13,233	$ 14,207	$ 13,619	$ 11,997
Cumulative Effect, Period of Adoption, Adjustment [Member] | Accounting Standards Update 2016-13 [Member]
Accounts Receivable, Allowance for Credit Loss	$ 500

Note 5 - Accounts Receivable -

Note 5 - Accounts Receivable - Summary of Accounts Receivable (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Gross accounts receivable	$ 62,835		$ 70,925
Unearned income	(2,467)		(3,354)
Allowance for expected credit losses	(13,233)	$ (14,207)	(13,619)	$ (11,997)
Accounts Receivable, after Allowance for Credit Loss	47,135		53,952
Current trade receivables	37,520		37,262
Current unearned interest income	(1,915)		(2,397)
Long-term trade receivables	12,082		20,044
Long-term unearned interest income	$ (552)		$ (957)

Note 5 - Accounts Receivable _2

Note 5 - Accounts Receivable - Schedule of Contractual Commitments, Net of Allowance for Doubtful Accounts (Details) $ in Thousands	Jun. 30, 2023 USD ($)
Total, current financing receivables, net	$ 28,259
2023, current financing receivables, net	16,177
2024, current financing receivables, net	10,334
2025, current financing receivables, net	1,734
2026, current financing receivables, net	14
2027, current financing receivables, net	0
Current Financing Receivables, Net Of Allowance [Member]
Total, current financing receivables, net	16,177
2023, current financing receivables, net	16,177
2024, current financing receivables, net	0
2025, current financing receivables, net	0
2026, current financing receivables, net	0
2027, current financing receivables, net	0
Noncurrent Financing Receivables, Net Of Allowance [Member]
Total, current financing receivables, net	12,082
2023, current financing receivables, net	0
2024, current financing receivables, net	10,334
2025, current financing receivables, net	1,734
2026, current financing receivables, net	14
2027, current financing receivables, net	$ 0

Note 5 - Accounts Receivable _3

Note 5 - Accounts Receivable - Allowance for Doubtful Accounts (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Balance	$ 14,207	$ 13,619	$ 13,619	$ 11,997	$ 11,997
Write-offs	(1,332)	(30)			(5,715)
Provision	358	618	977	$ 3,521	7,337
Balance	$ 13,233	$ 14,207	$ 13,233		$ 13,619

Note 6 - Select Balance Sheet_3

Note 6 - Select Balance Sheet and Statement of Operations Information (Details Textual) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Cost, Direct Material	$ 5,124	$ 7,731	$ 11,956	$ 15,231
Inventory Valuation Reserves	2,897		2,897		$ 3,258
Depreciation	$ 144	$ 309	$ 246	$ 490

Note 6 - Select Balance Sheet_4

Note 6 - Select Balance Sheet and Statement of Operations Information - Schedule of Property and Equipment, Net (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Raw materials	$ 2,211	$ 2,478
Work-in-progress	1,596	2,112
Finished goods	19,129	19,316
Total inventory	$ 22,936	$ 23,906

Note 6 - Select Balance Sheet_5

Note 6 - Select Balance Sheet and Statement of Operations Information - Property and Equipment, Net (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Lab equipment tooling and molds	$ 3,576	$ 4,356
Office furniture and equipment	1,249	1,240
Leasehold improvements	621	794
Computers and software	934	906
Demo units	214	214
Total property and equipment	6,631	7,547
Less: Accumulated depreciation	(4,991)	(5,690)
Total property and equipment, net	$ 1,640	1,857
Tools, Dies and Molds [Member] | Minimum [Member]
Property and equipment, Useful lives (Year)	4 years
Tools, Dies and Molds [Member] | Maximum [Member]
Property and equipment, Useful lives (Year)	10 years
Office Equipment [Member] | Minimum [Member]
Property and equipment, Useful lives (Year)	6 years
Office Equipment [Member] | Maximum [Member]
Property and equipment, Useful lives (Year)	10 years
Leasehold Improvements [Member] | Maximum [Member]
Property and equipment, Useful lives (Year)	10 years
Computer Equipment [Member]
Property and equipment, Useful lives (Year)	3 years
Vehicles [Member]
Vehicles	$ 37	$ 37
Vehicles [Member] | Minimum [Member]
Property and equipment, Useful lives (Year)	5 years
Vehicles [Member] | Maximum [Member]
Property and equipment, Useful lives (Year)	7 years
Demo Units [Member]
Property and equipment, Useful lives (Year)	5 years

Note 6 - Select Balance Sheet_6

Note 6 - Select Balance Sheet and Statement of Operations Information - Other Current Assets (Details) - USD ($) $ in Thousands		Jun. 30, 2023	Dec. 31, 2022
Government remittances (1)	[1]	$ 1,197	$ 1,602
Consideration receivable from subsidiaries sale		231	629
Deferred financing costs		4	301
Sundry assets and miscellaneous		552	1,170
Total other current assets		$ 1,984	$ 3,702
[1]Government remittances are receivables from the local tax authorities for refund of sales taxes and income taxes.

Note 6 - Select Balance Sheet_7

Note 6 - Select Balance Sheet and Statement of Operations Information - Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Payroll and related expense	$ 1,601	$ 2,244
Accrued expenses	4,023	5,045
Commission accrual	2,445	3,761
Sales and consumption taxes	4,994	5,617
Total accrued expenses and other current liabilities	$ 13,063	$ 16,667

Note 6 - Select Balance Sheet_8

Note 6 - Select Balance Sheet and Statement of Operations Information - Warranty Accrual (Details) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Balance as of the beginning of the period	$ 1,482	$ 1,753
Warranties issued during the period	78	993
Warranty costs incurred during the period	(303)	(1,264)
Balance at the end of the period	1,257	1,482
Current	880	1,074
Long-term	377	408
Total	$ 1,257	$ 1,482

Note 6 - Select Balance Sheet_9

Note 6 - Select Balance Sheet and Statement of Operations Information - Finance Expenses (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Interest expense	$ 1,487	$ 969	$ 2,930	$ 1,827
Accretion on long-term debt and amortization of fees	66	65	131	130
Total finance expenses	$ 1,553	$ 1,034	$ 3,061	$ 1,957

Note 7 - Leases - Lease Cost (D

Note 7 - Leases - Lease Cost (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Operating lease cost	$ 503	$ 607	$ 1,013	$ 941
Short-term lease cost	0	0	0	0
Total lease cost	503	607	1,013	941
Operating cash outflows from operating leases	$ 503	$ 607	$ 1,013	$ 941
Weighted-average remaining lease term (in years) (Year)	3 years 5 months 8 days	4 years 3 months 14 days	3 years 5 months 8 days	4 years 3 months 14 days
Weighted-average discount rate	4%	4%	4%	4%

Note 7 - Leases - Operating Lea

Note 7 - Leases - Operating Lease Maturity (Details) $ in Thousands	Jun. 30, 2023 USD ($)
2023, operating lease	$ 780
2024, operating lease	1,407
2025, operating lease	1,228
2026, operating lease	1,039
2027, operating lease	594
Thereafter, operating lease	544
Imputed Interest (1)	(355)
Total	$ 5,237

Note 8 - Intangible Assets (Det

Note 8 - Intangible Assets (Details Textual) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Amortization of Intangible Assets	$ 866	$ 865	$ 1,722	$ 1,722

Note 8 - Intangible Assets - Sc

Note 8 - Intangible Assets - Schedule of Intangible Assets Net of Accumulated Amortization and Goodwill (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Gross Amount	$ 23,800	$ 23,800
Accumulated amortization	(13,603)	(11,881)
Net Amount	10,197	11,919
Customer Relationships [Member]
Gross Amount	1,400	1,400
Accumulated amortization	(475)	(429)
Net Amount	925	971
Brand [Member]
Gross Amount	2,500	2,500
Accumulated amortization	(1,197)	(1,066)
Net Amount	1,303	1,434
Technology [Member]
Gross Amount	16,900	16,900
Accumulated amortization	(10,317)	(8,919)
Net Amount	6,583	7,981
Supplier Agreement [Member]
Gross Amount	3,000	3,000
Accumulated amortization	(1,614)	(1,467)
Net Amount	$ 1,386	$ 1,533

Note 8 - Intangible Assets - Es

Note 8 - Intangible Assets - Estimated Amortization (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
2023	$ 1,751
2024	3,473
2025	3,004
2026	656
2027	657
Thereafter	656
Total	$ 10,197	$ 11,919

Note 9 - Commitments and Cont_3

Note 9 - Commitments and Contingencies (Details Textual) $ in Thousands	6 Months Ended
	Jun. 30, 2023 USD ($)
Purchase Obligation	$ 15,086
Contract Manufacturers [Member]
Purchase Obligation	15,100
Open Purchase Order [Member]
Purchase Obligation	$ 700
Percentage Of Open Purchase Order	25%

Note 9 - Commitments and Cont_4

Note 9 - Commitments and Contingencies - Contractual Obligation Maturity (Details) $ in Thousands	Jun. 30, 2023 USD ($)
2023, purchase and service commitments	$ 15,086
2024 and Thereafter, purchase and service commitments	0
Total	$ 15,086

Note 10 - Main Street Term Lo_3

Note 10 - Main Street Term Loan (Details Textual) - MSLP Note [Member] - USD ($) $ in Millions		12 Months Ended
	Dec. 08, 2020	Dec. 08, 2024
Debt Instrument, Face Amount	$ 50
Debt Instrument, Term (Year)	5 years
Forecast [Member]
Debt Instrument, Percentage of Outstanding Principal to be Paid with Accrued Unpaid Interest		15%
London Interbank Offered Rate [Member]
Debt Instrument, Basis Spread on Variable Rate	3%

Note 10 - Main Street Term Lo_4

Note 10 - Main Street Term Loan - Schedule Payments on Outstanding Borrowings (Details) - MSLP Note [Member] $ in Thousands	Jun. 30, 2023 USD ($)
2023	$ 9,889
2024	10,239
2025	40,365
Total	$ 60,493

Note 11 - Madryn Long-term De_3

Note 11 - Madryn Long-term Debt and Convertible Notes (Details Textual) - USD ($)		3 Months Ended		6 Months Ended
	Dec. 09, 2020	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Common Stock, Par or Stated Value Per Share (in dollars per share)	$ 0.0001	$ 0.0001		$ 0.0001		$ 0.0001
Madryn Credit Agreement [Member]
Repayments of Debt	$ 42,500,000
Secured Subordinated Convertible Notes [Member] | Madryn Noteholders [Member]
Debt Instrument, Face Amount	$ 26,700,000
Long-Term Debt, Gross		$ 27,200,000		$ 27,200,000
Debt Instrument, Default, Increase in Interest Rate	4%
Debt Instrument, Termination, Minimum Principal Outstanding	$ 10,000
Debt Instrument, Convertible, Conversion Price (in dollars per share)	$ 48.75
Interest Expense		540,000	$ 540,000	1,074,000	$ 1,074,000
Repayments of Long-Term Debt		$ 0		$ 0
Debt Instrument, Maturity Date	Dec. 09, 2025
Secured Subordinated Convertible Notes [Member] | Madryn Noteholders [Member] | Original Issuance Of Notes To Third Anniversary Date [Member]
Debt Instrument, Interest Rate, Stated Percentage	8%
Secured Subordinated Convertible Notes [Member] | Madryn Noteholders [Member] | After the Third Anniversary [Member]
Debt Instrument, Interest Rate, Stated Percentage	6%

Note 11 - Madryn Long-term De_4

Note 11 - Madryn Long-term Debt and Convertible Notes - Scheduled Payments (Details) - Secured Subordinated Convertible Notes [Member] $ in Thousands	Jun. 30, 2023 USD ($)
2023	$ 1,608
2024	1,628
2025	28,217
Total	$ 31,453

Note 12 - Credit Facility (Deta

Note 12 - Credit Facility (Details Textual) - City National Bank of Florida [Member] - USD ($) $ in Millions	Aug. 26, 2021	Dec. 09, 2020
CNB Note [Member]
Debt Instrument, Face Amount	$ 5
Debt Instrument, Maturity Date	Jul. 24, 2023
Revolving Credit Facility [Member]
Line of Credit Facility, Minimum Deposit Required	$ 1.5	$ 3
Loan Processing Fee		1
Line of Credit Facility, Maximum Borrowing Capacity	$ 5	$ 10
Debt Instrument, LIBOR Floor	0.50%
Revolving Credit Facility [Member] | London Interbank Offered Rate [Member]
Debt Instrument, Basis Spread on Variable Rate	3.25%

Note 13 - Common Stock Reserv_3

Note 13 - Common Stock Reserved for Issuance - Common Stock Reserved for Issuance (Details) - $ / shares	Jun. 30, 2023	Dec. 31, 2022
Outstanding stock options and RSUs (in dollars per share)	$ 1,019,837	$ 875,524
Shares reserved for future option grants and RSUs (in shares)	64,292	24,999
Total common stock reserved for issuance (in shares)	14,149,339	6,378,417
Lincoln Park [Member]
Total common stock reserved for issuance (in shares)	711,180	1,054,299
Madryn Noteholders [Member]
Total common stock reserved for issuance (in shares)	558,666	547,714
Non-Voting Preferred Stock [Member]
Shares reserved for conversion of future preferred share issuance (in shares)	0	80,617
Voting Preferred Stock [Member]
Shares reserved for conversion of future preferred share issuance (in shares)	7,860,916	609,891
Common Stock [Member]
Outstanding common stock warrants (in shares)	1,061,930	1,061,930
Preferred Stock [Member]
Preferred shares (in shares)	2,872,518	2,123,443

Note 14 - Stockholders Equity_2

Note 14 - Stockholders Equity (Details Textual)							1 Months Ended				3 Months Ended			6 Months Ended		12 Months Ended		18 Months Ended	24 Months Ended	36 Months Ended
	May 15, 2023 USD ($) shares	May 11, 2023	May 11, 2023	May 10, 2023	Jul. 12, 2022 USD ($) $ / shares shares	Dec. 15, 2021 USD ($) $ / shares shares	Nov. 30, 2022 USD ($) $ / shares shares	Jul. 31, 2022 USD ($) shares	Nov. 30, 2017 shares	Nov. 30, 2010	Jun. 30, 2023 USD ($) $ / shares shares	Mar. 31, 2023 USD ($) shares	Jun. 30, 2022 USD ($) $ / shares shares	Jun. 30, 2023 USD ($) $ / shares shares	Jun. 30, 2022 USD ($) $ / shares	Jun. 30, 2023 USD ($) $ / shares shares	Dec. 31, 2022 USD ($) $ / shares shares	Jun. 30, 2023 USD ($) $ / shares shares	Jun. 30, 2022 USD ($)	Jun. 30, 2023 $ / shares shares	May 31, 2023 USD ($) $ / shares	Dec. 31, 2021 shares	Jul. 13, 2021 $ / shares	Dec. 09, 2020 $ / shares	Jun. 16, 2020 USD ($) $ / shares shares
Common Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares											$ 0.0001			$ 0.0001		$ 0.0001	$ 0.0001	$ 0.0001		$ 0.0001				$ 0.0001
Proceeds from Issuance of Common Stock														$ 1,109,000	$ 272,000
Stock Issued During Period, Value, New Issues											$ 71,000	$ 745,000	$ 48,000
Proceeds from Issuance of Private Placement														1,633,000	0
Payments of Stock Issuance Costs														$ 367,000
Common Stock, Capital Shares Reserved for Future Issuance (in shares) | shares											14,149,339			14,149,339		14,149,339	6,378,417	14,149,339		14,149,339
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments														$ 0
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value											$ 0		$ 0	$ 0	$ 0
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares											$ 3.38		$ 10.05	$ 2.89	$ 20.10
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value											$ 322,000		$ 411,000	$ 681,000	$ 775,000
The 2010 Share Option Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)									10 years	7 years
Common Stock, Capital Shares Reserved for Future Issuance (in shares) | shares									2,738								6,284
The 2019 Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares) | shares											30,000			30,000		30,000		30,000		30,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant (in shares) | shares											61,554			61,554		61,554	18,715	61,554		61,554
Share-based Compensation Arrangement by Share-based Payment Award, Increase in Authorized Shares, Percentage of Outstanding Stock Maximum														4%
Series A Preferred Stock [Member]
Preferred Stock, Shares Outstanding (in shares) | shares																						252,717
Voting Preferred Stock [Member]
Preferred Stock, Liquidation Preference Per Share (in dollars per share) | $ / shares							$ 30
Preferred Stock, Convertible, Conversion Ratio							0.6667
Preferred Stock, Convertible, Volume Weighted Average Price Per Common Share (in dollars per share) | $ / shares							$ 18.75
Senior Preferred Stock [Member]
Preferred Stock, Convertible, Conversion Ratio	2.6667
Liquidation Preference, Multiplier	2.50
Conversion Price, Benchmark, Multiplier	2.75
Common Stock [Member]
Stock Issued During Period, Shares, New Issues (in shares) | shares											118,729	224,378	26,667
Stock Issued During Period, Value, New Issues											$ 0	$ 1,000	$ 0
Equity Purchase Agreement [Member] | Lincoln Park [Member]
Equity Purchase Agreement, Maximum Offering Amount																									$ 31,000,000
Common Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares																									$ 0.0001
Equity Purchase Agreement, Maximum Shares Issuable (in shares) | shares																									517,560
Equity Agreement, Maximum Percentage of Stock Outstanding																									19.99%
Equity Agreement, Minimum Average Purchase Price (in dollars per share) | $ / shares																									$ 59.6325
Maximum Percentage of Outstanding Stock, Beneficial Ownership																									9.99%
Stock Issued During Period, Shares, New Issues (in shares) | shares								20,000									26,666,000			229,139
Shares Issued, Price Per Share (in dollars per share) | $ / shares											$ 40.50			$ 40.50		$ 40.50		$ 40.50		$ 40.50
Stock Issued During Period, Shares, Commitment Fee (in shares) | shares																				13,971
Stock Issued During Period, Value, Commitment Fee																			$ 620,000
Deferred Offering Costs													$ 123,000		$ 123,000		$ 0		$ 123,000
Proceeds from Issuance of Common Stock								$ 300,000									$ 272,000
LPC Purchase Agreement 2022 [Member] | Lincoln Park [Member]
Equity Purchase Agreement, Maximum Offering Amount					$ 11,000,000
Common Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares					$ 0.0001
Equity Purchase Agreement, Maximum Shares Issuable (in shares) | shares					858,224
Equity Agreement, Maximum Percentage of Stock Outstanding					19.99%
Maximum Percentage of Outstanding Stock, Beneficial Ownership					9.99%
Stock Issued During Period, Shares, New Issues (in shares) | shares					50,000									343,116		780,000	433,336
Shares Issued, Price Per Share (in dollars per share) | $ / shares											$ 3.23			$ 3.23		$ 3.23	$ 4.54	$ 3.23		$ 3.23			$ 3.97
Stock Issued During Period, Shares, Commitment Fee (in shares) | shares					45,701
Stock Issued During Period, Value, Commitment Fee					$ 330,000
Proceeds from Issuance of Common Stock																		$ 8,700,000
Stock Issued During Period, Value, New Issues					$ 300,000									$ 1,109,000		$ 3,100,000	$ 1,970,000
The 2021 Private Placement [Member]
Proceeds from Issuance of Private Placement						$ 17,000,000
Payments of Stock Issuance Costs						$ 300,000
The 2021 Private Placement [Member] | Convertible Preferred Stock [Member]
Stock Issued During Period, Shares, New Issues (in shares) | shares						252,717
Preferred Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares						$ 0.0001
The 2021 Private Placement [Member] | Common Stock [Member]
Stock Issued During Period, Shares, New Issues (in shares) | shares						653,894
The 2022 Private Placement [Member]
Proceeds from Issuance of Private Placement							$ 6,720,000
Payments of Stock Issuance Costs							$ 202,000
The 2022 Private Placement [Member] | Convertible Preferred Stock [Member]
Stock Issued During Period, Shares, New Issues (in shares) | shares							3,185,000
Preferred Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares							$ 0.0001
Preferred Stock, Convertible, Shares Issuable (in shares) | shares							2,123,443
The 2022 Private Placement [Member] | Common Stock [Member]
Common Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares							$ 0.0001
Stock Issued During Period, Shares, New Issues (in shares) | shares							116,668
Multi-Tranche Private Placement 2023 [Member]
Equity Purchase Agreement, Maximum Offering Amount																					$ 9,000,000
Equity Purchase Agreement, Minimum Aggregate Purchase Amount Per Tranche																					$ 500,000
Multi-Tranche Private Placement 2023 [Member] | Senior Preferred Stock [Member]
Stock Issued During Period, Shares, New Issues (in shares) | shares	280,899
Preferred Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares																					$ 0.0001
Proceeds from Issuance of Preferred Stock and Preference Stock	$ 2,000,000
Reverse Stock Split [Member]
Stockholders' Equity Note, Stock Split, Conversion Ratio		15	15
Reverse Stock Split [Member] | Minimum [Member]
Stockholders' Equity Note, Stock Split, Conversion Ratio				5
Reverse Stock Split [Member] | Maximum [Member]
Stockholders' Equity Note, Stock Split, Conversion Ratio				15

Note 14 - Stockholders Equity -

Note 14 - Stockholders Equity - Stock-based Compensation (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Total stock-based compensation	$ 369	$ 558	$ 850	$ 1,001
Cost of Sales [Member]
Total stock-based compensation	11	13	26	21
Selling and Marketing Expense [Member]
Total stock-based compensation	76	134	185	309
General and Administrative Expense [Member]
Total stock-based compensation	251	322	551	551
Research and Development Expense [Member]
Total stock-based compensation	$ 31	$ 89	$ 88	$ 120

Note 14 - Stockholders Equity_3

Note 14 - Stockholders Equity - Stock Options Assumptions (Details)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Expected term (in years) (Year)		6 years	6 years	6 years
Risk-free interest rate		2.92%
Risk-free interest rate, minimum			3.37%	2.56%
Risk-free interest rate, maximum			3.41%	2.92%
Expected volatility		42.89%	42.98%	42.56%
Expected dividend rate		0%	0%	0%
Minimum [Member]
Expected term (in years) (Year)	6 years
Risk-free interest rate	3.37%
Expected volatility	42.72%
Expected dividend rate	0%

Note 14 - Stockholders Equity_4

Note 14 - Stockholders Equity - Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Outstanding, number of shares (in shares)			849,600
Outstanding, weighted average exercise price (in dollars per share)			$ 25.05
Outstanding, weighted average remaining contractual term (Year)			7 years 11 months 1 day		8 years 2 months 23 days
Outstanding, aggregate intrinsic value	$ 0		$ 0		$ 209
Options granted, number of shares (in shares)			211,031
Options granted, weighted average exercise price (in dollars per share)			$ 2.89
Options granted, aggregate intrinsic value			$ 0
Options exercised, number of shares (in shares)			0
Options exercised, weighted average exercise price (in dollars per share)			$ 0
Options exercised, aggregate intrinsic value	$ 0	$ 0	$ 0	$ 0
Options forfeited/cancelled, number of shares (in shares)			(43,462)
Options forfeited/cancelled, weighted average exercise price (in dollars per share)			$ 35.07
Options forfeited/cancelled, aggregate intrinsic value (in dollars per share)			$ 0
Outstanding – June 30, 2023 (in shares)	1,017,169		1,017,169		849,600
Outstanding – June 30, 2023 (in dollars per share)	$ 20.05		$ 20.05		$ 25.05
Exercisable, number of shares (in shares)	276,841		276,841
Exercisable, weighted average exercise price (in dollars per share)	$ 48.22		$ 48.22
Exercisable, weighted average remaining contractual term (Year)			5 years 3 months 3 days
Exercisable, aggregate intrinsic value	$ 0		$ 0
Expected to vest, number of shares (in shares)	740,328		740,328
Expected to vest, weighted average exercise price (in dollars per share)	$ 9.51		$ 9.51
Expected to vest, weighted average remaining contractual term (Year)			8 years 10 months 28 days
Expected to vest, aggregate intrinsic value	$ 0		$ 0

Note 14 - Stockholders Equity_5

Note 14 - Stockholders Equity - Stock Options Outstanding and Exercisable (Details)	6 Months Ended
	Jun. 30, 2023 $ / shares shares
Options outstanding, number (in shares) | shares	1,017,169
Options outstanding, weighted average remaining contractual term (Year)	7 years 11 months 1 day
Options outstanding, weighted average exercise price (in dollars per share)	$ 20.05
Options exercisable (in shares) | shares	276,841
Options exercisable, weighted average remaining contractual term (Year)	5 years 3 months 3 days
Options exercisable, weighted average exercise price (in dollars per share)	$ 48.22
Range One [Member]
Exercise price range, lower limit (in dollars per share)	2.82
Exercise price range, upper limit (in dollars per share)	$ 54.60
Options outstanding, number (in shares) | shares	967,750
Options outstanding, weighted average remaining contractual term (Year)	8 years 1 month 13 days
Options outstanding, weighted average exercise price (in dollars per share)	$ 15.19
Options exercisable (in shares) | shares	228,587
Options exercisable, weighted average remaining contractual term (Year)	5 years 6 months 18 days
Options exercisable, weighted average exercise price (in dollars per share)	$ 33.94
Range Two [Member]
Exercise price range, lower limit (in dollars per share)	63.90
Exercise price range, upper limit (in dollars per share)	$ 119.25
Options outstanding, number (in shares) | shares	46,638
Options outstanding, weighted average remaining contractual term (Year)	3 years 11 months 1 day
Options outstanding, weighted average exercise price (in dollars per share)	$ 99.45
Options exercisable (in shares) | shares	45,473
Options exercisable, weighted average remaining contractual term (Year)	3 years 10 months 6 days
Options exercisable, weighted average exercise price (in dollars per share)	$ 99.76
Range Three [Member]
Exercise price range, lower limit (in dollars per share)	186.75
Exercise price range, upper limit (in dollars per share)	$ 382.50
Options outstanding, number (in shares) | shares	1,630
Options outstanding, weighted average remaining contractual term (Year)	5 years 2 months 26 days
Options outstanding, weighted average exercise price (in dollars per share)	$ 271.36
Options exercisable (in shares) | shares	1,630
Options exercisable, weighted average remaining contractual term (Year)	5 years 2 months 26 days
Options exercisable, weighted average exercise price (in dollars per share)	$ 271.36
Range Four [Member]
Exercise price range, lower limit (in dollars per share)	405
Exercise price range, upper limit (in dollars per share)	$ 438.75
Options outstanding, number (in shares) | shares	644
Options outstanding, weighted average remaining contractual term (Year)	1 year 9 months 14 days
Options outstanding, weighted average exercise price (in dollars per share)	$ 405.21
Options exercisable (in shares) | shares	644
Options exercisable, weighted average remaining contractual term (Year)	1 year 9 months 14 days
Options exercisable, weighted average exercise price (in dollars per share)	$ 405.21
Range Five [Member]
Exercise price range, lower limit (in dollars per share)	540
Exercise price range, upper limit (in dollars per share)	$ 958.50
Options outstanding, number (in shares) | shares	507
Options outstanding, weighted average remaining contractual term (Year)	4 years 5 months 8 days
Options outstanding, weighted average exercise price (in dollars per share)	$ 691.99
Options exercisable (in shares) | shares	507
Options exercisable, weighted average remaining contractual term (Year)	4 years 5 months 8 days
Options exercisable, weighted average exercise price (in dollars per share)	$ 691.99

Note 14 - Stockholders Equity_6

Note 14 - Stockholders Equity - Restricted Stock Units Activity (Details) - Restricted Stock Units (RSUs) [Member]	6 Months Ended
	Jun. 30, 2023 $ / shares shares
Outstanding, rsu (in shares) | shares	25,918
Outstanding, weighted average grant date fair value (in dollars per share) | $ / shares	$ 19.50
RSUs granted, rsu (in shares) | shares	0
RSUs granted, weighted average grant date fair value (in dollars per share) | $ / shares	$ 0
RSUs forfeited/cancelled, rsu (in shares) | shares	(1,250)
RSUs forfeited/cancelled, weighted average grant date fair value (in dollars per share) | $ / shares	$ 20.70
RSUs exercised, rsu (in shares) | shares	(22,000)
RSUs exercised, weighted average grant date fair value (in dollars per share) | $ / shares	$ 20.70
Outstanding, rsu (in shares) | shares	2,668
Outstanding, weighted average grant date fair value (in dollars per share) | $ / shares	$ 8.70

Note 15 - Income Taxes (Details

Note 15 - Income Taxes (Details Textual) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Income Tax Expense (Benefit)	$ 189	$ (18)	$ 424	$ 254

Note 15 - Income Taxes - Reconc

Note 15 - Income Taxes - Reconciliation of Income Tax Expense (Benefit) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Loss before income taxes	$ (7,132)	$ (10,530)	$ (16,520)	$ (18,894)
Theoretical tax expense at the statutory rate (21% in 2023 and 2022)	(1,484)	(2,211)	(3,456)	(3,968)
Differences in jurisdictional tax rates	(281)	(341)	(548)	(593)
Valuation allowance	1,890	2,118	4,332	4,185
Non-deductible expenses	65	418	97	631
Other	(1)	(2)	(1)	(1)
Total income tax provision (recovery)	189	(18)	424	254
Net loss	$ (7,321)	$ (10,512)	$ (16,944)	$ (19,148)

Note 15 - Income Taxes - Reco_2

Note 15 - Income Taxes - Reconciliation of Income Tax Expense (Benefit) (Details) (Parentheticals)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Statutory Rate	21%	21%	21%	21%

Note 16 - Segment and Geograp_3

Note 16 - Segment and Geographic Information (Details Textual) $ in Thousands	6 Months Ended
	Jun. 30, 2023 USD ($)	Dec. 31, 2022 USD ($)
Number of Reportable Segments	1
Leases [Member]
Sales with Typical Lease Terms (Month)	36 months
System [Member]
Sales with Payment Terms (Month)	12 months
UNITED STATES
Long-Lived Assets	$ 10,562	$ 12,346
Non-US [Member]
Long-Lived Assets	$ 1,275	$ 1,431

Note 16 - Segment and Geograp_4

Note 16 - Segment and Geographic Information - Schedule of Revenue by Geographic Area (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Total revenue	$ 20,075	$ 27,266	$ 40,606	$ 53,672
UNITED STATES
Total revenue	9,757	13,417	20,498	26,546
Non-US [Member]
Total revenue	$ 10,318	$ 13,849	$ 20,108	$ 27,126

Note 16 - Segment and Geograp_5

Note 16 - Segment and Geographic Information - Schedule of Revenue by Type (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Total revenue	$ 20,075	$ 27,266	$ 40,606	$ 53,672
Leases [Member]
Total revenue	4,311	11,874	10,072	22,297
System [Member]
Total revenue	12,313	11,548	23,377	23,422
Product [Member]
Total revenue	2,586	3,080	5,532	6,577
Service [Member]
Total revenue	$ 865	$ 764	$ 1,625	$ 1,376

Note 17 - Related Party Trans_2

Note 17 - Related Party Transactions (Details Textual) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2020	Jan. 01, 2021	Jan. 01, 2018
Revenue from Contract with Customer, Including Assessed Tax	$ 20,075	$ 27,266	$ 40,606	$ 53,672
Venus Concept Singapore Pte. Ltd (Venus Singapore) [Member]
Disposal Group, Including Discontinued Operation, Percentage of Ownership					55%
Technicalbiomed Co., Ltd. (TBC) [Member]
Revenue from Contract with Customer, Including Assessed Tax	114	329	322	736
Senior Officer [Member] | Technicalbiomed Co., Ltd. (TBC) [Member]
Equity Method Investment, Ownership Percentage						45%	30%
Venus Concept Singapore Pte. Ltd (Venus Singapore) [Member]
Revenue from Contract with Customer, Including Assessed Tax	$ 62	$ 141	$ 122	$ 319

Note 18 - Subsequent Events (De

Note 18 - Subsequent Events (Details Textual) - Multi-Tranche Private Placement 2023 [Member] - Senior Preferred Stock [Member] - USD ($)	Jul. 12, 2023	May 15, 2023
Stock Issued During Period, Shares, New Issues (in shares)		280,899
Proceeds from Issuance of Preferred Stock and Preference Stock		$ 2,000,000
Subsequent Event [Member]
Stock Issued During Period, Shares, New Issues (in shares)	500,000
Proceeds from Issuance of Preferred Stock and Preference Stock	$ 2,000,000